Update from Alcobra on Recent FDA Communications
Oct 07, 2016 12:48 pm UTC| Business
TEL AVIV, Israel, Oct. 07, 2016 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit...
Oct 07, 2016 12:30 pm UTC| Business
NORCROSS, Ga., Oct. 07, 2016 -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced it will present two posters...
Novolyze launches SurroNov(TM), a range of dry surrogate microorganisms
Oct 07, 2016 12:11 pm UTC| Business
DIJON, France, Oct. 07, 2016 -- Novolyze, a fast-growing food biotechnology company, announces the global launch of its new range of products: SurroNov(TM) www.novolyze.com SurroNov(TM) is a range of innovative...
ParkerVision Files Patent Infringement Complaint Against Apple in Germany
Oct 07, 2016 12:00 pm UTC| Business
JACKSONVILLE, Fla., Oct. 07, 2016 -- ParkerVision, Inc. (NASDAQ:PRKR), a developer, manufacturer and marketer of semiconductor technology solutions for wireless applications, announced today that its wholly-owned German...
Silicon Motion Announces Preliminary Third Quarter 2016 Revenue and Earnings Conference Call Details
Oct 07, 2016 12:00 pm UTC| Business
TAIPEI, Taiwan and MILPITAS, Calif., Oct. 07, 2016 -- Silicon Motion Technology Corporation (NasdaqGS: SIMO)(“Silicon Motion” or the “Company”), a global leader in designing and marketing NAND flash controllers for...
Novavax Reschedules 4th Annual Investor and Analyst Meeting
Oct 07, 2016 12:00 pm UTC| Business
GAITHERSBURG, Md., Oct. 07, 2016 -- Novavax, Inc., (Nasdaq:NVAX) today announced it has rescheduled its 4th annual Investor and Analyst Meeting. The Company will host an Investor and Analyst update as part of its third...
Otonomy Holds Investor and Analyst Day and Provides Corporate Update
Oct 07, 2016 12:00 pm UTC| Business
SAN DIEGO, Oct. 07, 2016 -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today held an...
FxWirePro- Major Economic events for the day
Rachel Reeves Faces Potential £25 Billion Tax Increase in Upcoming Budget to Support Public Services